[The relationships between the lipoprotein profile and rheological-coagulation parameters in patients with hyperlipoproteinemia type II]. 1992

M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
Istituto di Medicina e Chirurgia geriatrica, Università, Torino.

The aim of the study was to evaluate the direct influence of lipid parameters (total and HDL-cholesterol, triglycerides and total lipids) on the rheologic-coagulative pattern. We studied blood rheological properties--blood (BV), plasmatic (PV), and seric (SV) viscosity, whole blood (WBF) and red cell (RCF) filterability--and some coagulative factors--fibrinogen (Fib), levels of clotting factor VII (fVIIc) and VIII (fVIIIc) activity--in 156 men aged 40-54 years; 87 patients had type II hyperlipoproteinemia (46 type IIa and 41 type IIb) and 69 were normolipemic controls. Smokers, patients with arterial hypertension, diabetes mellitus or cardiovascular clinical manifestations were excluded. Type IIb hyperlipoproteinemic patients had increased blood viscosity (shear rate 225 sec-1, p. less than 0.01), which was positively correlated with triglycerides and fibrinogen concentration. Levels of fibrinogen, fVIIc and fVIIIc activity did not differ significantly in hyperlipemic patients and controls, although fVIIc activity and fibrinogen were both positively related with lipid parameters. These data suggest that, in absence of other major risk factors, the alterations of the rheologic-coagulative pattern are mainly dependent on the severity of the lipid disorder.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001809 Blood Viscosity The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA. Blood Viscosities,Viscosities, Blood,Viscosity, Blood
D005167 Factor VII Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa. Coagulation Factor VII,Proconvertin,Stable Factor,Blood Coagulation Factor VII,Factor 7,Factor Seven,Factor VII, Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
December 1979, Die Medizinische Welt,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
January 2014, Journal of clinical lipidology,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
June 1992, Minerva cardioangiologica,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
June 1972, The Journal of clinical investigation,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
March 1994, Diabetes care,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
May 1987, Atherosclerosis,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
February 2002, Journal of internal medicine,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
August 1983, Clinical chemistry,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
December 1991, International journal of obesity,
M Bo, and M Molaschi, and M Neirotti, and F Bonino, and M Gottero, and V Pedrazzini, and S Mainardi, and F Fabris
April 1986, The American journal of cardiology,
Copied contents to your clipboard!